Plerixafor

NDC 25021-416 · Sagent Pharmaceuticals

Generic namePlerixafor

Dosage formINJECTION, SOLUTION

RouteSUBCUTANEOUS

Active ingredient(s)PLERIXAFOR

Strength20 mg/mL

Pharmacologic classHematopoietic Stem Cell Mobilizer [EPC], Increased Hematopoietic Stem Cell Mobilization [PE]

Marketing categoryANDA

Packages

25021-416-01 — 1 VIAL in 1 CARTON (25021-416-01) / 1.2 mL in 1 VIAL

J2562 — Injection, plerixafor, 1 mg Medicare Part B payment limit (ASP + 6%): $28.49

FDA lists these products with the same active ingredient.

0024-5862 — PLERIXAFOR, 31722-373 — Plerixafor, 43598-308 — Plerixafor, 55150-356 — Plerixafor, 65219-284 — PLERIXAFOR, 68083-155 — Plerixafor, 70121-1694 — plerixafor, 70710-1208 — plerixafor, 70771-1776 — plerixafor, 71288-155 — Plerixafor, 72162-2642 — Plerixafor, 72205-249 — Plerixafor

From the FDA National Drug Code Directory, retrieved 2026-08-24. Product listings are submitted by labelers; FDA does not verify them.